Literature DB >> 7395908

Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome.

R B Lowry, S L Yong.   

Abstract

We report two sibs with the Smith-Lemli-Opitz (RSH) syndrome and intelligence in the borderline normal range. The proposita has all the features of the syndrome; however, her brother shows fewer signs, indicating that considerable variability of expression may exist for this autosomal recessive trait. Nearly all previous cases had severe to profound mental retardation. The incidence of the syndrome in British Columbia is approximately 1/40,000 live births, giving a heterozygote frequency of about 1/100.

Entities:  

Mesh:

Year:  1980        PMID: 7395908     DOI: 10.1002/ajmg.1320050205

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  19 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  Abnormalities of cholesterol metabolism in autism spectrum disorders.

Authors:  Elaine Tierney; Irena Bukelis; Richard E Thompson; Khalid Ahmed; Alka Aneja; Lisa Kratz; Richard I Kelley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-09-05       Impact factor: 3.568

Review 3.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

4.  De novo 2q+ masquerading as Smith-Lemli-Opitz syndrome.

Authors:  A E Donnenfeld; E H Zackai; D M McDonald; R Aquino; B S Emanuel
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

Review 5.  Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation.

Authors:  M J Nowaczyk; D T Whelan; T W Heshka; R E Hill
Journal:  CMAJ       Date:  1999-07-27       Impact factor: 8.262

6.  Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Josep Marcos; Cedric H L Shackleton; Madhavee M Buddhikot; Forbes D Porter; Gordon L Watson
Journal:  Steroids       Date:  2007-07-13       Impact factor: 2.668

7.  Determination of the allelic frequency in Smith-Lemli-Opitz syndrome by analysis of massively parallel sequencing data sets.

Authors:  J L Cross; J Iben; C L Simpson; A Thurm; S Swedo; E Tierney; J E Bailey-Wilson; L G Biesecker; F D Porter; C A Wassif
Journal:  Clin Genet       Date:  2014-06-06       Impact factor: 4.438

8.  Challenging behavior in Smith-Lemli-Opitz syndrome: initial test of biobehavioral influences.

Authors:  Kurt A Freeman; Rose Eagle; Louise S Merkens; Darryn Sikora; Kersti Pettit-Kekel; Mina Nguyen-Driver; Robert D Steiner
Journal:  Cogn Behav Neurol       Date:  2013-03       Impact factor: 1.600

9.  Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease.

Authors:  C Mueller; S Patel; M Irons; K Antshel; G Salen; G S Tint; C Bay
Journal:  Am J Med Genet A       Date:  2003-11-15       Impact factor: 2.802

10.  Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patient.

Authors:  T L Alley; B A Gray; S H Lee; S W Scherer; L C Tsui; G S Tint; C A Williams; R Zori; M R Wallace
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.